CHARMOT DOMINIQUE,DAVIDSON JAMES P,LIN FANGLING,JACOBS JEFFREY W,BLINOVA NATALIA,LABONTE ERIC,LANGSETMO INGRID,BLANKS ROBERT C
申请号：
IN201717026082
公开号：
IN201717026082A
申请日:
2017.07.21
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance. In particular the application discloses the use of crosslinked calcium polystyrene sulfonate with a crosslinking of less than 5%.
